173 related articles for article (PubMed ID: 20725056)
1. Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
Gupta AK; Poulter NR; Dobson J; Eldridge S; Cappuccio FP; Caulfield M; Collier D; Cruickshank JK; Sever PS; Feder G;
Am J Hypertens; 2010 Sep; 23(9):1023-30. PubMed ID: 20725056
[TBL] [Abstract][Full Text] [Related]
2. [ASCOT Study of optimal hypertension therapy. New study results against the "diuretics first" recommendation].
MMW Fortschr Med; 2005 Dec; 147(49-50):66-7. PubMed ID: 16402454
[No Abstract] [Full Text] [Related]
3. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
Williams B; Lacy PS; Thom SM; Cruickshank K; Stanton A; Collier D; Hughes AD; Thurston H; O'Rourke M; ; ;
Circulation; 2006 Mar; 113(9):1213-25. PubMed ID: 16476843
[TBL] [Abstract][Full Text] [Related]
4. [Antihypertensive therapy: campaign of the giants].
Füessl HS
MMW Fortschr Med; 2005 Dec; 147(51-52):28. PubMed ID: 16402700
[No Abstract] [Full Text] [Related]
5. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
[TBL] [Abstract][Full Text] [Related]
7. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Poulter NR; Dobson JE; Sever PS; Dahlöf B; Wedel H; Campbell NR;
J Am Coll Cardiol; 2009 Sep; 54(13):1154-61. PubMed ID: 19761936
[TBL] [Abstract][Full Text] [Related]
8. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
[TBL] [Abstract][Full Text] [Related]
9. Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
Collier DJ; Poulter NR; Dahlöf B; Sever PS; Wedel H; Buch J; Caulfield MJ;
J Hypertens; 2011 Mar; 29(3):583-91. PubMed ID: 21297503
[TBL] [Abstract][Full Text] [Related]
10. A new dimension in hypertension management with the amlodipine/perindopril combination.
Poulter NR
J Hypertens; 2011 Dec; 29 Suppl 1():S15-21. PubMed ID: 22157563
[TBL] [Abstract][Full Text] [Related]
11. The Anglo-Scandinavian Cardiac Outcomes Trial-- blood pressure lowering arm.
Coleman JJ; Kendall MJ
J Clin Pharm Ther; 2006 Aug; 31(4):299-307. PubMed ID: 16882098
[No Abstract] [Full Text] [Related]
12. [Treating essential hypertension. Are beta blockers still first choice?].
Rahn KH
MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
[No Abstract] [Full Text] [Related]
13. Results of the ASCOT-BPLA trial: no practical implications for treatment of hypertension.
Prescrire Int; 2006 Jun; 15(83):112. PubMed ID: 16764103
[TBL] [Abstract][Full Text] [Related]
14. Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
Gupta AK; Dahlof B; Dobson J; Sever PS; Wedel H; Poulter NR;
Diabetes Care; 2008 May; 31(5):982-8. PubMed ID: 18235048
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.
Tapp RJ; Sharp A; Stanton AV; O'Brien E; Chaturvedi N; Poulter NR; Sever PS; Thom SA; Hughes AD; Mayet J;
J Am Coll Cardiol; 2010 Apr; 55(17):1875-81. PubMed ID: 20413040
[TBL] [Abstract][Full Text] [Related]
16. Which patients benefit the most from the perindopril/amlodipine combination.
Mourad JJ
J Hypertens; 2011 Dec; 29 Suppl 1():S23-8. PubMed ID: 22157564
[TBL] [Abstract][Full Text] [Related]
17. A randomized, comparative, multicentric evaluation of atenolol/amlodipine combination with atenolol alone in essential hypertensive patients.
Pareek A; Salkar H; Mulay P; Desai S; Chandurkar N; Redkar N
Am J Ther; 2010; 17(1):46-52. PubMed ID: 19535971
[TBL] [Abstract][Full Text] [Related]
18. [The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].
van den Meiracker AH; van Montfrans GA
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):886-8. PubMed ID: 16686086
[TBL] [Abstract][Full Text] [Related]
19. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
20. Perindopril: first-line treatment for hypertension.
Zanchetti A; Desche P
Clin Exp Hypertens A; 1989; 11 Suppl 2():555-73. PubMed ID: 2691129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
